Jin Seok Kim
Researcher Next ID · RN-036697
Researcher · Biochemistry, Genetics and Molecular Biology
Seoul, South Korea
- Works count
- 778
- Citation count
- 13,141
- H-index
- 54
- i10-index
- 261
Research interests
Publications
Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis
New England Journal of Medicine · 2021 · https://doi.org/10.1056/nejmoa2028631
The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment
Kidney International · 2020 · https://doi.org/10.1016/j.kint.2020.01.035
The complement C5 inhibitor crovalimab in paroxysmal nocturnal hemoglobinuria
Blood · 2020 · https://doi.org/10.1182/blood.2019003399
Daratumumab plus lenalidomide and dexamethasone versus lenalidomide and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of POLLUX
Haematologica · 2018 · https://doi.org/10.3324/haematol.2018.194282
Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study
Leukemia · 2017 · https://doi.org/10.1038/leu.2017.138
A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis
The Lancet Oncology · 2016 · https://doi.org/10.1016/s1470-2045(15)00533-1
NAG-1/GDF-15 prevents obesity by increasing thermogenesis, lipolysis and oxidative metabolism
International Journal of Obesity · 2014 · https://doi.org/10.1038/ijo.2014.27
Clinical signs and symptoms associated with increased risk for thrombosis in patients with paroxysmal nocturnal hemoglobinuria from a Korean Registry
International Journal of Hematology · 2013 · https://doi.org/10.1007/s12185-013-1346-4
Crystal structure of the Mre11–Rad50–ATPγS complex: understanding the interplay between Mre11 and Rad50
Genes & Development · 2011 · https://doi.org/10.1101/gad.2037811
Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL)
BMC Cancer · 2011 · https://doi.org/10.1186/1471-2407-11-321
Comparison of treatment strategies for patients with intestinal diffuse large B-cell lymphoma: surgical resection followed by chemotherapy versus chemotherapy alone
Blood · 2010 · https://doi.org/10.1182/blood-2010-06-288480
Active locomotion of a paddling-based capsule endoscope in an in vitro and in vivo experiment (with videos)
Gastrointestinal Endoscopy · 2010 · https://doi.org/10.1016/j.gie.2009.12.058
Phase II Trial of Concurrent Radiation and Weekly Cisplatin Followed by VIPD Chemotherapy in Newly Diagnosed, Stage IE to IIE, Nasal, Extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma Study
Journal of Clinical Oncology · 2009 · https://doi.org/10.1200/jco.2009.23.8592
Protein Kinase CK2α as an Unfavorable Prognostic Marker and Novel Therapeutic Target in Acute Myeloid Leukemia
Clinical Cancer Research · 2007 · https://doi.org/10.1158/1078-0432.ccr-06-1602
Treatment of high‐risk acute myelogenous leukaemia by myeloablative chemoradiotherapy followed by co‐infusion of T cell‐depleted haematopoietic stem cells and culture‐expanded marrow mesenchymal stem cells from a related donor with one fully mismatched human leucocyte antigen haplotype
British Journal of Haematology · 2002 · https://doi.org/10.1046/j.1365-2141.2002.03767.x
Polyethylene glycol-grafted poly-l-lysine as polymeric gene carrier
Journal of Controlled Release · 1998 · https://doi.org/10.1016/s0168-3659(97)00174-0
Airway obstruction in asthmatic and healthy individuals: inspiratory and expiratory thin-section CT findings.
Radiology · 1997 · https://doi.org/10.1148/radiology.203.2.9114089
Current projects
No projects listed.